{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,12]],"date-time":"2026-10-12T12:02:48Z","timestamp":1791806568848,"version":"4.3.4"},"reference-count":25,"publisher":"Elsevier BV","issue":"4","license":[{"start":{"date-parts":[[2024,1,1]],"date-time":"2024-01-01T00:00:00Z","timestamp":1704067200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2024,1,1]],"date-time":"2024-01-01T00:00:00Z","timestamp":1704067200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2024,7,16]],"date-time":"2024-07-16T00:00:00Z","timestamp":1721088000000},"content-version":"vor","delay-in-days":197,"URL":"http:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0\/"}],"funder":[{"DOI":"10.13039\/100001039","name":"Cleveland Foundation","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100001039","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100000002","name":"National Institutes of Health","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100000002","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100000062","name":"NIDDK","doi-asserted-by":"publisher","award":["R01 DK122990"],"award-info":[{"award-number":["R01 DK122990"]}],"id":[{"id":"10.13039\/100000062","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100000062","name":"NIDDK","doi-asserted-by":"publisher","award":["R01 DK135566"],"award-info":[{"award-number":["R01 DK135566"]}],"id":[{"id":"10.13039\/100000062","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["clinicalkey.fr","clinicalkey.jp","cmghjournal.org","clinicalkey.com.au","clinicalkey.es","clinicalkey.com","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Cellular and Molecular Gastroenterology and Hepatology"],"published-print":{"date-parts":[[2024]]},"DOI":"10.1016\/j.jcmgh.2024.101380","type":"journal-article","created":{"date-parts":[[2024,7,20]],"date-time":"2024-07-20T12:43:09Z","timestamp":1721479389000},"page":"101380","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":11,"title":["Hepatocyte-specific Epidermal Growth Factor Receptor Deletion Promotes Fibrosis but has no Effect on Steatosis in Fast-food Diet Model of Metabolic Dysfunction-associated Steatotic Liver Disease"],"prefix":"10.1016","volume":"18","author":[{"given":"Shehnaz","family":"Bano","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Matthew A.","family":"Copeland","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"John W.","family":"Stoops","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Anne","family":"Orr","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Siddhi","family":"Jain","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Shirish","family":"Paranjpe","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Raja Gopal Reddy","family":"Mooli","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sadeesh K.","family":"Ramakrishnan","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Joseph","family":"Locker","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Wendy M.","family":"Mars","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"George K.","family":"Michalopoulos","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-1716-9764","authenticated-orcid":false,"given":"Bharat","family":"Bhushan","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.jcmgh.2024.101380_bib1","doi-asserted-by":"crossref","first-page":"151","DOI":"10.1016\/j.jhep.2018.09.014","article-title":"Burden of liver diseases in the world","volume":"70","author":"Asrani","year":"2019","journal-title":"J\u00a0Hepatol"},{"key":"10.1016\/j.jcmgh.2024.101380_bib2","doi-asserted-by":"crossref","first-page":"197","DOI":"10.7570\/jomes23052","article-title":"Metabolic dysfunction-associated steatotic liver disease (MASLD): a state-of-the-art review","volume":"32","author":"Chan","year":"2023","journal-title":"J\u00a0Obes Metab Syndr"},{"key":"10.1016\/j.jcmgh.2024.101380_bib3","doi-asserted-by":"crossref","first-page":"1183","DOI":"10.1016\/j.metabol.2016.04.004","article-title":"Pharmacological management of nonalcoholic fatty liver disease","volume":"65","author":"Barb","year":"2016","journal-title":"Metabolism"},{"key":"10.1016\/j.jcmgh.2024.101380_bib4","doi-asserted-by":"crossref","DOI":"10.1016\/j.cbi.2020.109090","article-title":"Role of epidermal growth factor receptor in liver injury and lipid metabolism: emerging new roles for an old receptor","volume":"324","author":"Bhushan","year":"2020","journal-title":"Chem Biol Interact"},{"key":"10.1016\/j.jcmgh.2024.101380_bib5","first-page":"211","article-title":"[Nuclear Her2 expression in hepatocytes in liver disease]","volume":"38","author":"Doring","year":"2017","journal-title":"Pathologe"},{"key":"10.1016\/j.jcmgh.2024.101380_bib6","doi-asserted-by":"crossref","first-page":"G370","DOI":"10.1152\/ajpgi.00116.2013","article-title":"Epidermal growth factor receptor plays a role in the regulation of liver and plasma lipid levels in adult male mice","volume":"306","author":"Scheving","year":"2014","journal-title":"Am J Physiol Gastrointest Liver Physiol"},{"key":"10.1016\/j.jcmgh.2024.101380_bib7","doi-asserted-by":"crossref","first-page":"1711","DOI":"10.1002\/hep.28721","article-title":"Combined systemic elimination of MET and epidermal growth factor receptor signaling completely abolishes liver regeneration and leads to liver decompensation","volume":"64","author":"Paranjpe","year":"2016","journal-title":"Hepatology"},{"key":"10.1016\/j.jcmgh.2024.101380_bib8","doi-asserted-by":"crossref","first-page":"604","DOI":"10.1002\/hep.28134","article-title":"Dissecting the role of epidermal growth factor receptor catalytic activity during liver regeneration and hepatocarcinogenesis","volume":"63","author":"Lopez-Luque","year":"2016","journal-title":"Hepatology"},{"key":"10.1016\/j.jcmgh.2024.101380_bib9","doi-asserted-by":"crossref","first-page":"1546","DOI":"10.1002\/hep.30696","article-title":"Pharmacologic inhibition of epidermal growth factor receptor suppresses nonalcoholic fatty liver disease in a murine fast-food diet model","volume":"70","author":"Bhushan","year":"2019","journal-title":"Hepatology"},{"key":"10.1016\/j.jcmgh.2024.101380_bib10","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0210828","article-title":"Epidermal growth factor receptor inhibition attenuates non-alcoholic fatty liver disease in diet-induced obese mice","volume":"14","author":"Choung","year":"2019","journal-title":"PLoS One"},{"key":"10.1016\/j.jcmgh.2024.101380_bib11","doi-asserted-by":"crossref","first-page":"133","DOI":"10.1016\/j.bbadis.2017.10.016","article-title":"Inhibition of EGFR attenuates fibrosis and stellate cell activation in diet-induced model of nonalcoholic fatty liver disease","volume":"1864","author":"Liang","year":"2018","journal-title":"Biochim Biophys Acta Mol Basis Dis"},{"key":"10.1016\/j.jcmgh.2024.101380_bib12","doi-asserted-by":"crossref","first-page":"2251","DOI":"10.1002\/hep.31604","article-title":"Hepatocyte nuclear factor 4alpha prevents the steatosis-to-NASH progression by regulating p53 and bile acid signaling (in mice)","volume":"73","author":"Xu","year":"2021","journal-title":"Hepatology"},{"key":"10.1016\/j.jcmgh.2024.101380_bib13","doi-asserted-by":"crossref","first-page":"G807","DOI":"10.1152\/ajpgi.00423.2015","article-title":"Hepatocyte ERBB3 and EGFR are required for maximal CCl4-induced liver fibrosis","volume":"311","author":"Scheving","year":"2016","journal-title":"Am J Physiol Gastrointest Liver Physiol"},{"key":"10.1016\/j.jcmgh.2024.101380_bib14","doi-asserted-by":"crossref","first-page":"G364","DOI":"10.1152\/ajpgi.00364.2014","article-title":"Loss of hepatocyte EGFR has no effect alone but exacerbates carbon tetrachloride-induced liver injury and impairs regeneration in hepatocyte Met-deficient mice","volume":"308","author":"Scheving","year":"2015","journal-title":"Am J Physiol Gastrointest Liver Physiol"},{"key":"10.1016\/j.jcmgh.2024.101380_bib15","doi-asserted-by":"crossref","first-page":"1577","DOI":"10.1002\/hep.26898","article-title":"Epidermal growth factor receptor inhibition attenuates liver fibrosis and development of hepatocellular carcinoma","volume":"59","author":"Fuchs","year":"2014","journal-title":"Hepatology"},{"key":"10.1016\/j.jcmgh.2024.101380_bib16","doi-asserted-by":"crossref","first-page":"1251","DOI":"10.1002\/hep.22437","article-title":"The epidermal growth factor receptor ligand amphiregulin participates in the development of mouse liver fibrosis","volume":"48","author":"Perugorria","year":"2008","journal-title":"Hepatology"},{"key":"10.1016\/j.jcmgh.2024.101380_bib17","doi-asserted-by":"crossref","first-page":"30","DOI":"10.3390\/ijms17010030","article-title":"EGFR signaling in liver diseases","volume":"17","author":"Komposch","year":"2015","journal-title":"Int J Mol Sci"},{"key":"10.1016\/j.jcmgh.2024.101380_bib18","doi-asserted-by":"crossref","first-page":"40","DOI":"10.1038\/s41575-020-0342-4","article-title":"Liver regeneration: biological and pathological mechanisms and implications","volume":"18","author":"Michalopoulos","year":"2021","journal-title":"Nat Rev Gastroenterol Hepatol"},{"key":"10.1016\/j.jcmgh.2024.101380_bib19","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0039552","article-title":"Efficacy of EGFR inhibition is modulated by model, sex, genetic background and diet: implications for preclinical cancer prevention and therapy trials","volume":"7","author":"Rinella","year":"2012","journal-title":"PLoS One"},{"key":"10.1016\/j.jcmgh.2024.101380_bib20","doi-asserted-by":"crossref","first-page":"231","DOI":"10.1002\/cbf.290060403","article-title":"Epidermal growth factor receptor numbers in male and female mouse primary hepatocyte cultures","volume":"6","author":"Benveniste","year":"1988","journal-title":"Cell Biochem Funct"},{"key":"10.1016\/j.jcmgh.2024.101380_bib21","first-page":"671","article-title":"Sex difference of EGFR expression and molecular pathway in the liver: impact on drug design and cancer treatments?","volume":"7","author":"Wang","year":"2016","journal-title":"J\u00a0Cancer"},{"key":"10.1016\/j.jcmgh.2024.101380_bib22","doi-asserted-by":"crossref","first-page":"2017","DOI":"10.1053\/gast.2002.37060","article-title":"Diverse expression of ErbB receptor proteins during rat liver development and regeneration","volume":"123","author":"Carver","year":"2002","journal-title":"Gastroenterology"},{"key":"10.1016\/j.jcmgh.2024.101380_bib23","doi-asserted-by":"crossref","first-page":"459","DOI":"10.1002\/ar.1092240402","article-title":"Circadian variation of epidermal growth factor receptor in mouse liver","volume":"224","author":"Scheving","year":"1989","journal-title":"Anat Rec"},{"key":"10.1016\/j.jcmgh.2024.101380_bib24","doi-asserted-by":"crossref","first-page":"G825","DOI":"10.1152\/ajpgi.00145.2011","article-title":"Fast food diet mouse: novel small animal model of NASH with ballooning, progressive fibrosis, and high physiological fidelity to the human condition","volume":"301","author":"Charlton","year":"2011","journal-title":"Am J Physiol Gastrointest Liver Physiol"},{"key":"10.1016\/j.jcmgh.2024.101380_bib25","doi-asserted-by":"crossref","first-page":"585","DOI":"10.1016\/j.jcmgh.2021.03.011","article-title":"Hypoxia via ERK signaling inhibits hepatic PPARalpha to promote fatty liver","volume":"12","author":"Mooli","year":"2021","journal-title":"Cell Mol Gastroenterol Hepatol"}],"container-title":["Cellular and Molecular Gastroenterology and Hepatology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S2352345X24001358?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S2352345X24001358?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2024,9,18]],"date-time":"2024-09-18T12:34:57Z","timestamp":1726662897000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S2352345X24001358"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2024]]},"references-count":25,"journal-issue":{"issue":"4","published-print":{"date-parts":[[2024]]}},"alternative-id":["S2352345X24001358"],"URL":"https:\/\/doi.org\/10.1016\/j.jcmgh.2024.101380","relation":{},"ISSN":["2352-345X"],"issn-type":[{"value":"2352-345X","type":"print"}],"subject":[],"published":{"date-parts":[[2024]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Hepatocyte-specific Epidermal Growth Factor Receptor Deletion Promotes Fibrosis but has no Effect on Steatosis in Fast-food Diet Model of Metabolic Dysfunction-associated Steatotic Liver Disease","name":"articletitle","label":"Article Title"},{"value":"Cellular and Molecular Gastroenterology and Hepatology","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.jcmgh.2024.101380","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2024 The Authors. Published by Elsevier Inc. on behalf of the AGA Institute.","name":"copyright","label":"Copyright"}],"article-number":"101380"}}